At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- WuXi AppTec's CRDMO Model: Integrating Research, Development, and Manufacturing into a Unified Platform April 17, 2026 7:37 am EIN Presswire SAN DIEGO , CA, UNITED STATES, April 17, 2026 /EINPresswire.com/ -- In today’s life sciences landscape, the journey from discovery to patient access remains long, complex, and resource-intensive. WuXi AppTec, a global CRDMO (Contract Research, …
- Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight April 16, 2026 5:00 pm EIN Presswire New York, USA, April 16, 2026 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight The non-small cell lung cancer clinical trial analysis report delivers …
- Global Rare Neurological Disease Treatment Market Dominated by North America as Germany Emerges with Bayer AG & Pfizer April 16, 2026 12:08 pm EIN Presswire Germany strengthens its role as a biotech hub, driven by gene therapy, RNA treatments, and precision medicine, shaping neurological care through 2035. ROCKVILLE, MD, UNITED STATES, April 16, 2026 /EINPresswire.com/ -- According to the latest …
- <![CDATA[LogiPharma 2026: Seamus Keane on Building Smarter Supply Networks]]> April 16, 2026 10:42 am Pharmaceutical Commerce As global pharmaceutical supply chains continue to face pressure from geopolitical volatility and shifting trade dynamics, the conversation around resilience is evolving beyond contingency planning. At LogiPharma Europe 2026, industry leaders are zeroing …
- From Supply Chain Risk to Supply Chain Advantage: How Indian CDMOs Are Reshaping Global Pharma April 16, 2026 2:54 am ETPharma.com For decades, the global supply chains that pervade pharmaceutical manufacturing have pursued one all-important goal: efficiency. The recipe for success was cost savings, scale and just-in-time sourcing. But the system didn’t accurately weigh its fragility …
- Iran war impact: Essential drugs may cost up to 5% more April 15, 2026 10:11 pm ETPharma.com Mumbai: The Centre is considering a proposal for a temporary 10-15% increase in the prices of select essential medicines to ease cost pressures faced by drugmakers, top industry executives aware of the discussions told ET. The immediate net consumer impact …
- Building ESG and human rights across the pharma supply chain April 15, 2026 7:34 pm Consultancy.org The pharma sector is under growing pressure to strengthen ESG performance across its supply chains, driven by regulations such as CSRD and CSDDD and rising expectations on human rights and decarbonisation. Experts from Nexio Projects explain how pharma …
- Curative Biotech Engages Sterling Pharma for Clinical Supply of Metformin-Based Ophthalmic Treatment April 15, 2026 5:54 pm Contract Pharma Curative Biotechnology is engaging Sterling Pharmaceutical Services to manufacture clinical supply of a metformin-based topical ophthalmic formulation. Sterling, a Dupo, Ill.-based CDMO, specializes in formulation development and manufacturing of sterile …
- 2 Day Online Course: Finance For Non-Financial Leaders In The UK And Global Pharmaceutical Industry April 15, 2026 4:09 pm MENAFN (MENAFN- GlobeNewsWire - Nasdaq) Enhance financial literacy in the pharmaceutical sector by equipping non-financial leaders with skills to interpret financial outcomes, connect them with regulatory frameworks, and drive strategic decisions. This blends …
- Bioactive Sphingolipid Market Expands at 5.1% CAGR with Merck, Doosan, Evonik, Cayman Chemical, Beckmann-Kenko, APL etc April 15, 2026 2:53 pm EIN Presswire The Bioactive Sphingolipid Market is segmented by Product Type, Source (Synthetic and Natural), Application, and Region. Forecast for 2026 to 2036. ROCKVILLE, MD, UNITED STATES, April 15, 2026 /EINPresswire.com/ -- According to Fact.MR’s latest …
- Nanodelivery of Gentiopicroside for Inflammatory Skin Lesions: Insights from Psoriasis and Diabetic Foot Ulcers April 15, 2026 2:29 pm Dove Medical Press Introduction A variety of inflammation-associated skin lesions pose great challenges to global public health. Representative conditions include psoriasis (PsO) and diabetic foot ulcer (DFU), both characterized by skin barrier disruption and persistent …
- Global Electrosynthesis Service Market: UK Emerges as Innovation Hub Led by Merck, ESy-Labs, VoltaChem April 15, 2026 10:53 am EIN Presswire UK market accelerates on green chemistry mandates, battery material innovation, and CRO-led scale-up capabilities through 2036 ROCKVILLE, MD, UNITED STATES, April 15, 2026 /EINPresswire.com/ -- The UK electrosynthesis service market is gaining …
- 5 biopharma M&A deals where the workforce was the prize April 15, 2026 9:48 am BioSpace Pharma M&A deals tend to revolve around key assets that can bolster the pipeline and provide growth. But sometimes, the buyer sees a lot more in the expertise within the target organization. That was the case with Gilead Sciences’ recent acquisition of …
- Global Phenol Crystals Market: Brazil Emerges as a Strategic Growth Hub Led by INEOS, Mitsui Chemicals, and Kumho P&B April 15, 2026 6:03 am EIN Presswire Brazil’s phenol crystals market accelerates on petrochemical expansion, polymer demand, supply chain integration, shaping long-term growth outlook through 2036 ROCKVILLE, MD, UNITED STATES, April 15, 2026 /EINPresswire.com/ -- The Brazil phenol …
- Iran war impact: Essential drugs may cost up to 5% more, for now April 15, 2026 3:39 am ETCFO.com The Centre is considering a proposal for a temporary 10-15% increase in the prices of select essential medicines to ease cost pressures faced by drugmakers, top industry executives aware of the discussions told ET. The immediate net consumer impact could …
- Pharma 5.0, Sustainability & Security: PHARMAP 2026 brings pharma’s future into focus April 14, 2026 10:08 pm Pharmaceutical Technology As the pharmaceutical industry navigates a series of interconnected industry challenges, the pharma community’s attention turns to Amsterdam. Later this month, major sector players gather for PHARMAP Congress 2026, scheduled for 20–21 April in the …
- EU sees 2025 pharma export uptick amid competitiveness concerns April 14, 2026 10:08 pm Pharmaceutical Technology New figures debuted by the European Union (EU) have uncovered a significant rise in the year-on-year value of pharma trade seen across the region in 2025 – stats the EU says represent a record trade balance for its medicines sector. In 2025, the value of …
- Huge Careers Fair at free pharma and life sciences conference in Cork April 14, 2026 9:42 pm Cork Beo This article contains affiliate links, we will receive a commission on any sales we generate from it. Learn more Gary O’Brien, ISPE Ireland Secretary (Flexachem), Philip Gammell, ISPE Ireland Chair (Astellas), Carolann Power, ISPE Ireland Affiliate Manager …
- Two years on from its launch, how has the UPC impacted European patent litigation in the life sciences sector? April 14, 2026 9:10 pm JD Supra - California The UPC has been reshaping European patent litigation since its launch in June 2023. More than 480 patents have now been litigated in the court, and the number of actions is steadily increasing1. Initially, major pharmaceutical players were reluctant to …
- The Rise of Experimental Data Lakes April 14, 2026 6:38 pm Datanami At BigDATAwire we have covered how AI is reshaping scientific discovery in more ways than we could have ever thought. AI is acting as a catalyst for breakthroughs in everything from drug discovery and climate modeling to materials science and advanced …
- Questex’s Fierce Biotech Announces 2026 Fierce Outsourcing Award Winners, Honoring Excellence Across the Drug Development Ecosystem April 14, 2026 4:00 pm EIN Presswire NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech today announces the winners of the 2026 Fierce Outsourcing Awards, recognizing the companies and teams driving innovation, performance, and partnership across the outsourced drug …
- Generic Sterile Injectable Market Size to Lead USD 124.44 Billion by 2035 Rising Demand for Affordable Injectables and Patent Expirations April 14, 2026 2:32 pm EIN Presswire Ottawa, April 14, 2026 (GLOBE NEWSWIRE) -- According to Precedence Research, the global generic sterile injectable market size will grow from USD 56.41 billion in 2026 to nearly USD 124.44 billion by 2035, accelerating with a solid CAGR of 9.29% from 2026 …
- SCW.AI and PharmaPhixx Announce Partnership to Accelerate Digital Transformation in Pharmaceutical Manufacturing April 14, 2026 1:00 pm EIN Presswire SCW.AI and PharmaPhixx partner to accelerate digital transformation by combining real-time production data with engineering support. ATLANTA, GA, UNITED STATES, April 14, 2026 /EINPresswire.com/ -- SCW.AI, a global leader in digital factory …
- Novo Nordisk partners with OpenAI to AI-power drug development April 14, 2026 12:21 pm Computer Weekly Danish pharmaceutical company Novo Nordisk has partnered with OpenAI to support drug research and development. Through the partnership, Novo Nordisk said it plans to deploy advanced artificial intelligence (AI) capabilities to analyse complex datasets, …
- Novo Nordisk and OpenAI forge alliance to drive speedy drug development April 14, 2026 11:10 am Pharmaceutical Technology Novo Nordisk has partnered with tech giant OpenAI to expedite its drug development efforts, as the Danish pharma looks to fend off stiff competition from obesity market rival Eli Lilly. Through this collaboration, Novo will incorporate OpenAI’s artificial …